FTSE 100 Posts Longest Winning Streak In More Than 5 Years,
Entain gains after BetMGM swings to benefit
Deliveroo jumps 17% after DoorDash takeover proposition
FTSE 100 flat, FTSE 250 gains 0.6%
(Updates after markets close)
April 28 (Reuters) - British equities ended higher on Monday with heavyweight healthcare companies leading gains in the benchmark index, while U.S. trade policy advancements remained in focus.
The blue-chip FTSE 100 was nearly flat however posted its 11th consecutive winning session. The index also posted its longest winning streak because December 2019.
The midcap FTSE 250 got 0.6%.
Healthcare stocks acquired 1.1%, with AstraZeneca and GSK boosting the highest gains in the FTSE 100, up 1.2% and 1.4% respectively.
Market sentiment was supported by indications of relieving U.S.-China trade tensions recently. However, unpredictabilities about the international trade war continued.
Entain ended up 6.8%, after the British gambling firm's joint endeavor with MGM Resorts, BetMGM, swung to first-quarter earnings in an e-betting rise.
Deliveroo jumped 16.5%, leading the gains on the midcap index, after on Friday that it had actually gotten a takeover proposition from U.S. peer DoorDash on April 5.
On the data side, British retail sales volumes fell by the smallest amount because October this month but stores expect conditions to worsen next month, according to a study that reflected issues about development and consumer confidence.
Britain has proposed a broad statement of shared worths with the European Union that emphasises assistance for Ukraine's territorial integrity, the Paris Climate Agreement and open and totally free trade, according to a draft file seen by Reuters.
Although it does not mention the Trump administration by name, several aspects of the text provide a striking contrast to existing U.S. policies.
Separately, trade ministers of UK and India began two days of speak to conclude more than 3 years of settlements on a trade pact, under extra pressure to reach a deal due to the fact that of U.S. President Donald Trump's tariffs on exports to the U.S. (Reporting by Sanchayaita Roy and Ragini Mathur in Bengaluru; Editing by Varun H K, William Maclean)